All In Biotech

Drug Trial Radar · NCT07220083

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled Trial to Assess the Effects of Oral TRPC6 Inhibitor BI 764198 Taken Over a 104 Week Treatment Period in Adult and Adolescent Participants With Primary Focal Segmental Glomerulosclerosis (pFSGS) or Genetic FSGS Related to TRPC6 Gene Variants

Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 286 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

286

Planned (sponsor's estimate)

Start

Feb 16, 2026

Primary completion

Dec 27, 2028

Study completion Jan 24, 2029

Sponsor

Lead sponsor
Boehringer IngelheimBoehringer Ingelheim
Sponsor type
Industry
First posted
Oct 23, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

PODOMOUNT-pFSGS This study is open to adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS). The purpose of this study is to find out whether a medicine called BI 764198 helps people with FSGS. Participants are put into 2 groups randomly, which means by chance. Every participant has an equal chance of being in each group. One group takes BI 764198 tablets, and the other group takes placebo tablets. Placebo tablets look like BI 764198 tablets but do not contain any medicine. Participants take a tablet once a day for up to 2 years. All participants also continue their standard medication for FSGS. Participants are in the study for up to 2 years. During this time, they visit the study site about every 3 months. Participants regularly collect urine samples. This is done to check their kidneys. The results are compared between the two groups to see whether the treatment works. The doctors also regularly check participants' health and take note of any unwanted effects.

Conditions

  • Focal Segmental Glomerulosclerosis

Interventions

  • BI 764198Drug

    BI 764198

  • PlaceboDrug

    Placebo matching BI 764198

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Relative change in 24-hour UPCR (measured in mg/g) from baseline to Week 104Time frame: Baseline and Week 104

Locations

309 sites in 37 countries. Site status is shown where the registry gives one.

  • Alabama Kidney Research

    Alabaster, Alabama · Recruiting

  • Apogee Clinical Research

    Huntsville, Alabama · Recruiting

  • Southwest Kidney Institute

    Surprise, Arizona · Recruiting

  • West Coast Kidney Institute

    Fremont, California · Recruiting

  • Kidney Disease Medical Group

    Glendale, California · Recruiting

  • Amicis Research Center - Balboa

    Granada Hills, California · Recruiting

  • Valiance Clinical Research

    Huntington Park, California · Recruiting

  • Academic Medical Research Institute - Glendale

    Los Angeles, California · Recruiting

  • Kaiser Permanente - Los Angeles Medical Center

    Los Angeles, California · Recruiting

  • University of California Los Angeles

    Los Angeles, California · Not yet recruiting

  • Valley Renal Medical Group - Northridge

    Northridge, California · Not yet recruiting

  • Shasta Critical Care Specialists

    Redding, California · Recruiting

  • North America Research Institute

    San Dimas, California · Recruiting

  • Kaiser Permanente - French Campus

    San Francisco, California · Recruiting

  • Valiance Clinical Research-Tarzana-68237

    Tarzana, California · Recruiting

  • National Institute of Clinical Research - Victorville

    Victorville, California · Recruiting

  • Kidney Associates of Colorado - Denver

    Denver, Colorado · Recruiting

  • Colorado Kidney Care

    Denver, Colorado · Recruiting

  • Florida Kidney Physicians - Boca Raton

    Boca Raton, Florida · Recruiting

  • Florida Kidney Physicians, LLC - Fort Lauderdale

    Fort Lauderdale, Florida · Recruiting

  • Total Research Group, LLC

    Miami, Florida · Recruiting

  • CTR Oakwater, LLC

    Orlando, Florida · Recruiting

  • Coastal Nephrology and Associates

    Port Charlotte, Florida · Recruiting

  • Florida Kidney Physicians - Riverview/Brandon

    Riverview, Florida · Recruiting

  • Emory Children's Center

    Atlanta, Georgia · Not yet recruiting

  • Coastal Medical Research, LLC

    Brunswick, Georgia · Recruiting

  • Southeast Kidney Associates - East Point

    East Point, Georgia · Recruiting

  • Memorial Health University Hospital

    Savannah, Georgia · Recruiting

  • Ann & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois · Not yet recruiting

  • Northwestern University

    Chicago, Illinois · Not yet recruiting

  • Endeavor Health

    Evanston, Illinois · Recruiting

  • Kidney Care Center - Olympia Fields

    Olympia Fields, Illinois · Recruiting

  • Nephrology Physicians - Mishawaka

    Mishawaka, Indiana · Recruiting

  • EmVenio Research Inc. - Kansas City

    Kansas City, Kansas · Recruiting

  • Wichita Nephrology Group

    Wichita, Kansas · Recruiting

  • Renal Associates of Baton Rouge

    Baton Rouge, Louisiana · Recruiting

  • Northwest Louisiana Nephrology

    Shreveport, Louisiana · Recruiting

  • Johns Hopkins Hospital

    Baltimore, Maryland · Recruiting

  • Joslin Diabetes Center

    Boston, Massachusetts · Not yet recruiting

  • Henry Ford Hospital

    Detroit, Michigan · Recruiting

Showing 40 of 309 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.